Oral Immunonutrition Therapy to Reduce Acute Toxicity After Neoadjuvant Chemoradiotherapy Pancreatic Cancer Patients

NCT06736678 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Neoadjuvant Chemoradiotherapy
Immunonutrition

Interventions

DIETARY_SUPPLEMENT: Oral Immunonutrition

Sponsor

Sun Yat-sen University